Role of The Ouabain-Like Factor and Na-K Pump in Rat and Human Genetic Hypertension

References

• Ferrari P., Bianchi G. Membrane ion transports in hypertension. Handbook of Hypertension: Pathophysiology of Hypertension, W. H. Birkenhager, J. L. Reid. Elsevier Science. 1997; vol. 17: 935–974
   Google Scholar
• Haddy F. J., Overbeck H. W. The role of humoral agents in volume expanded spo hypertension. Life Sciences 1976; 19: 935–948
   PubMed Web of Science ®Google Scholar
• De Wardener H. E., Mac Gregor G. A. Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int. 1980; 18: 1–9
   PubMed Web of Science ®Google Scholar
• Blaustein M. Sodium ions, calcium ions, blood pressure regulation and hypertension: a reassessment and a hypothesis. Am. J. Physiol. 1977; 1(3)C165–C173
   Google Scholar
• Tymiak A. A., Norman J. A., Bolgar M., Di Donato G. C., Lee H., Parker W. L., Lo L. C., Berova N., Nakanishi K., Haber E., Haupert G. T. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc Natl Acad Sci USA. 1993; 90: 8189–8193
   PubMed Web of Science ®Google Scholar
• Zhao N., Lo L. C., Berova N., Nakanishi K., Tymiak A., Ludens J. H., Haupert G. T. Na-K ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry 1995; 34: 9893–9896
   PubMed Web of Science ®Google Scholar
• Lewis L. K., Yandle T. G., Lewis J. G., Richards A. M., Pidgeon G. B., Kaaja R. J., Nicholls M. G. Ouabain Is not detectable in human plasma. Hypertension. 1994; 24: 549–555
   PubMed Web of Science ®Google Scholar
• Gomez-Sanchez E. P., Foecking M. F., Sellers D., Blankenship M. S., Gomez-Sanchez C. E. Is the circulating ouabain-like compound ouabain?. Am J Hypertens. 1994; 7: 647–650
   PubMed Web of Science ®Google Scholar
• Kelly R. A., Smith T. W. Is ouabain the endogenous digitalis?. Circulation 1992; 86(2)694–697
   PubMed Web of Science ®Google Scholar
• Nicholls M. G., Richards A. M., Lewis L. K., Yandle T. G. Ouabain: a new steroid hormone?. The Lancet 1995; 346: 1381–1382
   PubMed Web of Science ®Google Scholar
• Hansen O. Do putative endogenous digitalis-like factors have a physiological role?. Hypertension 1994; 24(5)640–642
   PubMed Web of Science ®Google Scholar
• Barber B. R., Ferrari P., Bianchi G. The Milan hypertensive strain: a description of the model. Handbook of Hypertension, D. Ganten, W. De Jong. Elsevier, Amsterdam 1994; 316–345
   Google Scholar
• Ferrandi M., Minotti E., Salardi S., Florio M., Bianchi G., Ferrari P. Ouabainlike factor in Milan hypertensive rats. Am J Physiol. 1992; 263: F739–F748
   Google Scholar
• Ferrandi M., Minotti E., Florio M., Bianchi G., Ferrari P. Age-dependency and dietary influence on the hypothalamic ouabain-like factor in Milan hypertensive rats. J Hypertens. 1995; 13: 1571–1574
   PubMed Web of Science ®Google Scholar
• Bianchi G., Fox U., Di Francesco G F, Bardi U., Radice M. The hypertensive role of the kidney in spontaneous hypertensive rats. Clin. Sci. Mol. Med. 1973; 45: 135s–139s
   PubMedGoogle Scholar
• Bianchi G., Fox U., Di Francesco G. F., Giovanetti A. M., Pagetti D. Blood pressure changes produced by kidney crosstransplantation between spontaneously hypertensive rats and normotensive rats. Clin. Sci. Mol. Med. 1974; 47: 435–448
   PubMedGoogle Scholar
• Ferrari P., Cusi D., Barber B. R., Barlassina C., Vezzoli G., Duzzi L., Minotti E., Bianchi G. Erythrocyte membrane and renal function in relation to hypertension in rats of the Milan hypertensive strain. Clin. Sci. 1982; 63: 61s–64s
   Google Scholar
• Bianchi G., Baer P. G., Fox U., Duzzi L., Pagetti D., Giovanetti A M. Changes in renin, water balance and sodium balance during development of high blood pressure in genetically hypertensive rats. Circ. Res. 1975; 36–37(suppl. 1)I-153–I-161
   Google Scholar
• Boberg U., Persson E. G. Increased tubuloglomerular feedback activity in Milan hypertensive rats. Am. J. Physiol. 1986; 250: F967–F974
   PubMed Web of Science ®Google Scholar
• Hanozet G. M., Parenti P., Salvati P. Presence of a potential sensitive Na+transport across renal brush border membrane vesicles from rats of the Milan hypertensive strain. Biochim. Biophys. Acta 1985; 819: 179–186
   PubMed Web of Science ®Google Scholar
• Ferrandi M., Salardi S., Parenti P., Ferrari P., Bianchi G., Braw R., Karlish S. Na+/K+/CI cotransporter mediated Rb+fluxes in membrane vesicles from kidneys of hypertensive and normotensive rats. Biochim. Biophys. Acta 1990; 1021: 13–20
   PubMed Web of Science ®Google Scholar
• Melzi M. L., Bertorello A., Fukuda Y., Muldin I., Sereni F., Aperia A. Na,K-ATPase activity in renal tubule cells from Milan hypertensive rats. Am. J Hypertens. 1989; 2: 563–566
   PubMed Web of Science ®Google Scholar
• Parenti P., Villa M., Hanozet G. M., Ferrandi M., Ferrari P. Increased Na pump activity in the kidney cortex of the Milan hypertensive rat strain. FEBS Lett. 1991; 290: 200–204
   PubMed Web of Science ®Google Scholar
• Ferrandi M., Tripodi G., Salardi S., Florio M., Modica R., Barassi P., Parenti P., Shainskaya A., Karlish S., Bianchi G., Ferrari P. Renal Na-K ATPase in genetic hypertension. Hypertension 1996; 28: 1018–1025
   PubMed Web of Science ®Google Scholar
• Foulkes R., Ferrario R., Salvati P., Bianchi G. Differences in ouabain-induced natriuresis between isolated kidneys of Milan hypertensive and normotensive rats. Clin. Sci. 1992; 82: 185–190
   PubMed Web of Science ®Google Scholar
• Bianchi G., Ferrari P. A genetic approach to the pathogenesis of primary hypertension and to its treatment. Clin. Experim. Pharmacol. Physiol. 1995; (S2): S399–S405
   Google Scholar
• Guidi E., Menghetti D., Milani Pharm S., Montagnino G., Palazzi P., Bianchi G. Hypertension may be transplanted with the kidney in humans. J. Am. Soc. Nephrology 1996, in press
   PubMedGoogle Scholar
• Bianchi G., Cusi D., Gatti M., Lupi G. P., Ferrari P., Barlassina C., Picotti G. B., Bracchi G., Colombo G., Gori D., Velis O., Mazzei D. A renal abnormality as a possible cause of “essential” hypertension. Lancet 1979; I: 173–177
   Google Scholar
• Bianchi G., Cusi D., Barlassina C., Lupi G. P., Ferrari P., Picotti G. B., Gatti M., Polli E. Renal dysfunction as a possible cause of essential hypertension in predisposed subjects. Kidney Intern. 1983; 23: 870–875
   PubMed Web of Science ®Google Scholar
• Bianchi G., Tripodi G., Casari G., Salardi S., Barber B R, Garcia R., Leoni P., Torielli L, Cusi D., Ferrandi M., Pinna L A, Baralle F E, Ferrari P. Two point mutations within the adducin gene are involved in blood pressure variation. Proc. Natl. Acad. Sci. USA 1994; 91: 3999–4003
   PubMed Web of Science ®Google Scholar
• Casari G., Barlassina C., Cusi D., Zagato L., Muirhead R., Righetti M., Nembri P., Amar K., Gatti M., Macciardi F, Binelli G., Bianchi G. Association of the α-adducin locus with essential hypertension. Hypertension 1995; 25: 320–326
   PubMed Web of Science ®Google Scholar
• Cusi D., Barlassina C., Azzani T., Casari G., Citterio L., Devoto M., Glorioso N., Lanzani C., Manunta P., Righetti M., Rivera R., Stella P., Troffa C., Zagato L., Bianchi G. Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension. Lancet 1997; 349: 1353–1357
   PubMed Web of Science ®Google Scholar
• Hughes C A, Bennett V. Adducin: a physical model with implications for function in assembly of spectrin-actin complexes. J Biol. Chem. 1995; 270: 18990–18996
   PubMed Web of Science ®Google Scholar
• Tripodi G., Valtorta F., Torielli L., Chieregatti E., Salardi S., Trusolino L., Menegon A., Ferrari P., Marchisio P C, Bianchi G. Hypertension-associated point mutations in the adducin α and β subunits affect actin cytoskeleton and ion transport. J Clin. Invest. 1996; 97: 2815–2822
   PubMed Web of Science ®Google Scholar
• Manunta P., Rogowski A. C., Hamilton B. P., Hamlyn J. M. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens. 1994; 12: 549–560
   PubMed Web of Science ®Google Scholar
• Ferrandi M., Manunta P., Balzan S., Hamlyn J., Bianchi G., Ferrari P. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension 1997, in press
   PubMed Web of Science ®Google Scholar
• Harris D. W., Clark M. A., Fisher J. F., Hamlyn J. M., Kolbasa K. P., Ludens J. H., Du Charme D. W. Development of an immunoassay for endogenous digitalis-like factor. Hypertension. 1991; 17: 936–943
   PubMed Web of Science ®Google Scholar
• Tamura M., Harris T M, Phyllis D., Blair I. A., Wang Y., Hellerquist C. G. Identification of two cardiac glycosides as Na-pump inhibitors in rat urine and diet. J Biol. Chem. 1994; 269: 11972–11979
   PubMed Web of Science ®Google Scholar
• Rossi G. P., Manunta P., Hamlyn J. M., Pavan E., De Toni R., Semplicini A., Pessina A. C. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels. J Hypertens. 1995; 13: 1181–1191
   PubMed Web of Science ®Google Scholar
• Manunta P., Rogowski A. C., Hamilton B. P., Hamlyn J. M. Ouabain-induced hypertension in the rat: relationships among plasma and tissue ouabain and blood pressure. J Hypertens. 1994; 12: 549–560
   PubMed Web of Science ®Google Scholar
• Quadri L., Bianchi G., Cerri A., Fedrizzi G., Ferrari P., Gobbini M., Melloni P., Sputore S., Torri M. 17 β-(3-Furyl)-5β-androstane-3β-14β-17α-triol (PST 2238): a very potent antihypertensive agent with a novel mechanism of action. J Med. Chem. 1997; 40: 1561–1564
   Google Scholar
• Ferrari P., Torielli L., Ferrandi M., Conti F., Duzzi L., Minotti E., Bianchi G. PST 2238, the new antagonist of the long-term ouabain pressor effect lowers blood pressure by modulating the Na-K ATPase at cell level. (Abs). J Hypertension 1997; 15(suppl. 4)P2.35
   Google Scholar